Breakthrough in Arthritis Treatment: Aging Protein Halted, Cartilage Regenerated.

Breakthrough in Arthritis Treatment: Aging Protein Halted, Cartilage Regenerated
Breakthrough in Arthritis Treatment: Aging Protein Halted, Cartilage Regenerated

According to ТСН: Researchers from Stanford University School of Medicine have made significant progress in treating osteoarthritis by developing a method that regenerates worn cartilage by blocking a specific 'aging protein'.

The new therapy is based on reprogramming joint cells, allowing them to regenerate tissue autonomously. This discovery could potentially free millions from the need to undergo complex surgeries on knee or hip joints.

Role of the 15-PGDH Protein

The research highlights the important role of the 15-PGDH protein, also known as gerosine. Its concentration in the body increases with age, leading to tissue degradation and reduced muscle strength. Scientists were able to alter the genetic activity of chondrocytes—the cells that produce cartilage—by blocking this protein with a specific molecule.

Instead of releasing pro-inflammatory molecules and breaking down collagen, old cells revert to a 'younger' state and begin to actively form new functional cartilage. Experiments on aged mice showed impressive results: after injections of the drug, cartilage tissue in the animals' knees significantly thickened, and their mobility was restored.

Treatment Effectiveness

The treatment also proved effective for acute injuries, particularly in preventing the development of post-traumatic arthritis after cruciate ligament tears. Human tissues obtained during surgeries also demonstrated a similar response to the therapy, initiating the process of natural regeneration within a week of treatment.

This therapy, unlike many modern methods, does not require the use of stem cells, making it safer and easier to implement. One version of the drug in pill form is currently undergoing the first phase of clinical trials in humans.

Researchers hope that specialized tests for patients suffering from joint diseases will begin in the near future. If successful, a course of injections or oral medications could completely replace joint replacement surgery, addressing the cause of the disease rather than just its symptoms.

In particular, the discovery related to osteoarthritis research could mark an important step in medicine. It has the potential to change the approach to treating joint diseases, reducing the need for surgical interventions. The continuation of clinical trials will be the next step in studying a therapy that promises to improve the quality of life for thousands.


Read also

Advertising